Evidence map›Paper›PMID 38482148›Full record

ArticleThe Lancet regional health. Southeast Asia2024

The burden of dengue and force of infection among children in Kerala, India; seroprevalence estimates from Government of Kerala-WHO Dengue study.

Pillaveetil Sathyadas Indu, Thekkumkara Surendran Anish, Sujatha Chintha, Gnanaseelan Kanakamma Libu, Lawrence Tony, Nalinakshan Sudha Siju, Easwaran Sreekumar, Asokan Santhoshkumar, Reghukumar Aravind, Karunakaran Lalithabai Saradadevi and 14 more

Open access · diamondAbstract read
In one paragraph

Article in The Lancet regional health. Southeast Asia, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Reconciling heterogeneous dengue virus infection risk estimates from different study designs.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 7 institutions in 2 countries.

Pillaveetil Sathyadas InduDepartment of Community Medicine, Govt Medical College, Thiruvananthapuram, Kerala University of Health Sciences, India.
Thekkumkara Surendran AnishDepartment of Community Medicine, Govt Medical College, Thiruvananthapuram, Kerala University of Health Sciences, India.
Sujatha ChinthaDepartment of Community Medicine, Govt Medical College, Thiruvananthapuram, Kerala University of Health Sciences, India.
Gnanaseelan Kanakamma LibuDepartment of Community Medicine, Govt Medical College, Thiruvananthapuram, Kerala University of Health Sciences, India.
Lawrence TonyDepartment of Community Medicine, Govt Medical College, Thiruvananthapuram, Kerala University of Health Sciences, India.
Nalinakshan Sudha SijuDepartment of Community Medicine, Govt Medical College, Thiruvananthapuram, Kerala University of Health Sciences, India.
Easwaran SreekumarMolecular Virology Laboratory, Rajiv Gandhi Centre for Biotechnology (RGCB), Thiruvananthapuram, Kerala, India.
Asokan SanthoshkumarDepartment of Paediatrics, Govt Medical College, Thiruvananthapuram, Kerala University of Health Sciences, India.
Reghukumar AravindDepartment of Infectious Diseases, Govt Medical College, Thiruvananthapuram, Kerala University of Health Sciences, India.
Karunakaran Lalithabai SaradadeviDepartment of Microbiology, Govt Medical College, Thiruvananthapuram, Kerala University of Health Sceinces, India.
Sahadevan SunijaState Public Health Lab, Kerala, India.
Jaichand JohnsonState Public Health Lab, Kerala, India.
Madhukumar Geethakumari AnupriyaMolecular Virology Laboratory, Rajiv Gandhi Centre for Biotechnology (RGCB), Thiruvananthapuram, Kerala, India.
Thomas MathewDirectorate of Medical Education, Kerala, India.
Kalathil Joseph ReenaDirectorate of Health Services, Kerala, India.
Vasu MeenakshyDirectorate of Health Services, Kerala, India.
Premaletha NamithaDepartment of Community Medicine, Govt Medical College, Thiruvananthapuram, Kerala University of Health Sciences, India.
Narendran Pradeep KumarIndian Council of Medical Research - Vector Control Research Centre, India.
Roop KumariIndia Country Office-WHO, New Delhi, India.
Ahmed Jamsheed MohamedSouth East Asia Region Office-WHO, New Delhi, India.
Bhupender NagpalSouth East Asia Region Office-WHO, New Delhi, India.
Swarup SarkarSouth East Asia Region Office-WHO, New Delhi, India.
Rajeev SadanandanDepartment of Health and Family Welfare, Govt of Kerala, India.
Raman VelayudhanDepartment of Control of Neglected Tropical Diseases, WHO, Geneva, Switzerland.
Kerala University of Health Sciences · INGovernment of Kerala · INWorld Health Organization Regional Office for South-East Asia · INRajiv Gandhi Centre for Biotechnology · INDrugs for Neglected Diseases Initiative · CHIndian Council of Medical Research · INWorld Health Organization - India · IN

Funding

World Health Organization 001
6 · The paper itself

Abstract

Background: Dengue shows high geographic heterogeneity within and across endemic countries. In the context of increasing burden and predicted outbreaks due to climate change, understanding the heterogeneity will enable us to develop region specific targeted interventions, including vaccination. World Health Organisation (WHO) suggests standard methodologies to study the burden and heterogeneity at national and subnational levels. Regional studies with robust and standard methodology to capture heterogeneity are scarce. We estimated the seroprevalence of dengue in children aged 9-12 years and the force of infection in Kerala, India, from where Zika cases also have been reported recently. Methods: We conducted a school-based cross-sectional survey in 38 clusters; selected by stratified random sampling, representing rural, urban, high burden and low-burden administrative units. Validation of Indirect IgG ELISA was done by Plaque Reduction Neutralization Test (PRNT Results: Among 5236 children tested, 1521 were positive for anti-dengue IgG antibody. The overall seroprevalence in the state was 29% (95% CI 24.1-33.9). The validity corrected seroprevalence was 30.9% in the overall sample, 46.9% in Thiruvananthapuram, 26.9% in Kozhikkode and 24.9% in Kollam. Age-specific seroprevalence increased with age; 25.7% at 9 years, 29.5% at 10 years, 30.9% at 11 years and 33.9% at 12 years. Seroprevalence varied widely across clusters (16.1%-71.4%). The estimated force of infection was 3.3/100 person-years and the seroconversion rate was 4.8/100 person-years. 90% of children who tested positive were not aware of dengue infection. All the four serotypes were identified in PRNT and 40% of positive samples had antibodies against multiple serotypes. Interpretation: The study validates the WHO methodology for dengue serosurveys and confirms its feasibility in a community setting. The overall seroprevalence in the 9-12 year age group is low to moderate in Kerala; there are regional variations; high burden and low burden clusters co-exist in the same districts. The actual burden of dengue exceeds the reported numbers. Heterogeneity in prevalence, the high proportion of inapparent dengue and the hyperendemic situation suggest the need for region-specific and targeted interventions, including vaccination. Funding: World Health Organization.

Indexed as

Burden of dengue: force of infectionGovt of Kerala-WHO Dengue studySeroconversion in dengueSeroprevalence of dengueSerprevalence of dengue in childrenValidation of IgG against PRNT, Plaque Reduction Neutralisation Test

Identifiers

PMID38482148
PMCPMC10934323
OpenAlexW4389560411

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.